Latest news
Merck lifts 2026 outlook as profits surge &Bio-Techne deal strengthens growth push - Indian Chemical NewsIndian Chemical News · Fri, 07 Aug 2026 08:49:06 GMTChip materials boom lifts Merck KGaA earnings, outlook - Communications TodayCommunications Today · Fri, 07 Aug 2026 03:15:35 GMTRecon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPSRAPS · Thu, 06 Aug 2026 18:15:00 GMTMerck KGaA lifts guidance as bioprocessing and chips offset healthcare - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 18:05:32 GMT[MKKGY Q2 2026 Earnings Call] Merck KGaA Hikes Full-Year Profit Target to €6.3 Billion as Bioprocessing and AI Demand Drive Q2 Beat - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 14:56:00 GMTMerck KGaA Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 14:04:22 GMTMerck Lifts Revenue View, Halves Profit Forecast - communitynews.orgcommunitynews.org · Thu, 06 Aug 2026 12:18:08 GMTLilly beats forecasts as Mounjaro, Zepbound drive 48% revenue surge - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 11:50:30 GMT